Skip to main content
. 2022 Jun 26;10(7):1294. doi: 10.3390/microorganisms10071294

Table 2.

Antiviral enzyme inhibitors and the antiviral mechanisms/targets.

Antiviral Drugs Mechanisms/Targets Virus IC50/EC50 Value Reference
Paxlovid 3CLpro and CYP3A4 SARS-CoV-2, HIV-1 - [39,40]
3-(aminocarbonyl)-1-phenylpyridinium; 2,3-dichloroaphthoquinone Mpro (Cys144, Glu165, Gln191) PEDV, FIPV EC50 = 100 μM [42]
Hexachlorophenol Mpro and ATPase SARS-CoV - [43]
Xanthohumol Mpro BVDV, HSV-1, HSV-2, RhV, PEDV, SARS-CoV-2 IC50 = 1.53 µM and 7.51 µM [44,45,46,47]
Tomatidine 3CLpro PEDV, TGEV, PRRSV, EMCV, SVA, PEDV - [51]